A detailed history of New Millennium Group LLC transactions in Novartis Ag stock. As of the latest transaction made, New Millennium Group LLC holds 267 shares of NVS stock, worth $30,867. This represents 0.02% of its overall portfolio holdings.

Number of Shares
267
Holding current value
$30,867
% of portfolio
0.02%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$92.57 - $107.37 $24,716 - $28,667
267 New
267 $28,000
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $17,619 - $19,554
-186 Reduced 41.06%
267 $27,000
Q2 2023

Aug 03, 2023

SELL
$92.52 - $104.91 $23,407 - $26,542
-253 Reduced 35.84%
453 $45,000
Q1 2023

Apr 28, 2023

BUY
$80.03 - $92.81 $960 - $1,113
12 Added 1.73%
706 $64,000
Q4 2022

Feb 07, 2023

SELL
$75.55 - $92.52 $151 - $185
-2 Reduced 0.29%
694 $62,000
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $74 - $87
-1 Reduced 0.14%
696 $53,000
Q2 2022

Aug 18, 2022

BUY
$80.52 - $93.75 $56,122 - $65,343
697 New
697 $58,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track New Millennium Group LLC Portfolio

Follow New Millennium Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Millennium Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Millennium Group LLC with notifications on news.